Payment overview · 2025
General Payments
$191.00
10 reported records · 4 companies
Healthcare provider profile · identity verified
Patrick W Griffith, MD
Allopathic & Osteopathic Physicians|Internal Medicine · JENNINGS, LA · NPI 1194828301
Verified facts
What the public records show
CMS Open Payments records show Patrick W Griffith, MD received $191.00 in general payments during 2025 across 10 reported records.
ABBVIE INC. accounted for 34.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro, Trintellix.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 178 claims for Synthroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Vraylar by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 175 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 64 claims for Trulicity by this doctor in 2024.
Takeda Pharmaceuticals U.S.A., Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRINTELLIX as an associated drug or biological on 37075 records involving 14402 distinct recipient NPIs. Public Medicare Part D data also shows 32 claims for Trintellix by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $65.60 | 34.4% | 3 | 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $56.52 | 29.6% | 3 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $52.22 | 27.3% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $16.66 | 8.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $191.00 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $65.60 | 3 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $65.60 | 3 | 2025 |
Source payment records
|
|||||
| TRINTELLIX Normalized: trintellix |
Drug | Takeda Pharmaceuticals U.S.A., Inc. | $56.52 | 3 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $52.22 | 3 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $34.15 | 2 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $16.66 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 175 | exact normalized | Medicare Part D |
| TRINTELLIX trintellix |
2025 | Trintellix | 2024 | 32 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
37 | 12 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
178 | 35 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | VRAYLAR open payments reported associated product |
CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550 |
Vraylar · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
175 | 29 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
64 | suppressed by CMS |
| Takeda Pharmaceuticals U.S.A., Inc. Exact reporting entity; no affiliate inference |
2025 | TRINTELLIX open payments reported associated product |
CMS Open Payments — General Payments 37075 supporting records · 14402 recipient NPIs · example record 1223616266 |
Trintellix · 2024 Exact normalized brand match · 1 Part D row |
32 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1257 | 263 |
| Alprazolam | Alprazolam | 922 | 132 |
| Pantoprazole Sodium | Pantoprazole Sodium | 904 | 199 |
| Atorvastatin Calcium | Atorvastatin Calcium | 666 | 165 |
| Gabapentin | Gabapentin | 640 | 95 |
| Amlodipine Besylate | Amlodipine Besylate | 539 | 129 |
| Meloxicam | Meloxicam | 475 | 105 |
| Furosemide | Furosemide | 455 | 122 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 445 | 113 |
| Escitalopram Oxalate | Escitalopram Oxalate | 436 | 77 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 418 | 91 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 408 | 92 |
| Metoprolol Succinate | Metoprolol Succinate | 367 | 81 |
| Metformin Hcl | Metformin Hcl | 347 | 93 |
| Lisinopril | Lisinopril | 346 | 81 |
| Losartan Potassium | Losartan Potassium | 337 | 77 |
| Methylprednisolone | Methylprednisolone | 328 | 232 |
| Zolpidem Tartrate | Zolpidem Tartrate | 322 | 42 |
| Glimepiride | Glimepiride | 321 | 80 |
| Hydrochlorothiazide | Hydrochlorothiazide | 308 | 69 |
| Montelukast Sodium | Montelukast Sodium | 286 | 66 |
| Buspirone Hcl | Buspirone Hcl | 283 | 55 |
| Levofloxacin | Levofloxacin | 283 | 192 |
| Tamsulosin Hcl | Tamsulosin Hcl | 268 | 69 |
| Potassium Chloride | Potassium Chloride | 262 | 50 |
| Temazepam | Temazepam | 257 | 46 |
| Azithromycin | Azithromycin | 242 | 185 |
| Trazodone Hcl | Trazodone Hcl | 241 | 45 |
| Celecoxib | Celecoxib | 218 | 34 |
| Omeprazole | Omeprazole | 214 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 204 | 45 |
| Simvastatin | Simvastatin | 204 | 40 |
| Ezetimibe | Ezetimibe | 203 | 44 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 201 | 33 |
| Diclofenac Sodium | Diclofenac Sodium | 199 | 42 |
| Lorazepam | Lorazepam | 193 | 24 |
| Famotidine | Famotidine | 185 | 43 |
| Fluoxetine Hcl | Fluoxetine Hcl | 183 | 37 |
| Donepezil Hcl | Donepezil Hcl | 181 | 35 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 179 | 93 |
| Synthroid | Levothyroxine Sodium | 178 | 35 |
| Ropinirole Hcl | Ropinirole Hcl | 177 | 29 |
| Mounjaro | Tirzepatide | 175 | 29 |
| Allopurinol | Allopurinol | 169 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 169 | 41 |
| Sertraline Hcl | Sertraline Hcl | 167 | 30 |
| Pioglitazone Hcl | Pioglitazone Hcl | 166 | 34 |
| Nebivolol Hcl | Nebivolol Hcl | 163 | 24 |
| Eliquis | Apixaban | 151 | 20 |
| Ozempic | Semaglutide | 143 | 24 |
| Duloxetine Hcl | Duloxetine Hcl | 142 | 34 |
| Clonazepam | Clonazepam | 140 | 17 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 138 | 19 |
| Bupropion Xl | Bupropion Hcl | 137 | 28 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 136 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 135 | 29 |
| Prednisone | Prednisone | 134 | 85 |
| Citalopram Hbr | Citalopram Hydrobromide | 131 | 29 |
| Tramadol Hcl | Tramadol Hcl | 128 | 38 |
| Metformin Hcl Er | Metformin Hcl | 125 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 121 | 31 |
| Tizanidine Hcl | Tizanidine Hcl | 121 | 30 |
| Fluticasone Propionate | Fluticasone Propionate | 120 | 42 |
| Pregabalin | Pregabalin | 114 | 20 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 113 | 77 |
| Clonidine Hcl | Clonidine Hcl | 102 | 24 |
| Benazepril Hcl | Benazepril Hcl | 101 | 24 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 101 | 17 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 100 | 26 |
| Warfarin Sodium | Warfarin Sodium | 97 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 95 | 21 |
| Paroxetine Hcl | Paroxetine Hcl | 93 | 18 |
| Xarelto | Rivaroxaban | 92 | 12 |
| Torsemide | Torsemide | 89 | 29 |
| Fenofibrate | Fenofibrate Nanocrystallized | 88 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 88 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 87 | 19 |
| Diazepam | Diazepam | 86 | 18 |
| Dicyclomine Hcl | Dicyclomine Hcl | 84 | 20 |
| Ibuprofen | Ibuprofen | 83 | 16 |
| Finasteride | Finasteride | 80 | 18 |
| Fenofibrate | Fenofibrate | 75 | 15 |
| Memantine Hcl | Memantine Hcl | 74 | 13 |
| Carvedilol | Carvedilol | 71 | 19 |
| Myrbetriq | Mirabegron | 71 | 12 |
| Fluconazole | Fluconazole | 69 | 48 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 65 | 41 |
| Sucralfate | Sucralfate | 64 | 18 |
| Trulicity | Dulaglutide | 64 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 63 | 26 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 58 | 13 |
| Estradiol | Estradiol | 56 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 55 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 54 | 14 |
| Gemfibrozil | Gemfibrozil | 54 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 53 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 51 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 50 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 50 | 11 |
| Alendronate Sodium | Alendronate Sodium | 49 | 11 |
| Np Thyroid | Thyroid,pork | 49 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 49 | 12 |
| Levetiracetam | Levetiracetam | 48 | suppressed |
| Nifedipine Er | Nifedipine | 47 | 13 |
| Spironolactone | Spironolactone | 47 | 12 |
| Glipizide | Glipizide | 46 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 46 | 20 |
| Atenolol | Atenolol | 45 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 45 | suppressed |
| Digoxin | Digoxin | 44 | suppressed |
| Eszopiclone | Eszopiclone | 44 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 43 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 42 | 29 |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 41 | 11 |
| Ondansetron Odt | Ondansetron | 40 | 27 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 39 | suppressed |
| Tradjenta | Linagliptin | 39 | suppressed |
| Cefdinir | Cefdinir | 38 | 35 |
| Lovastatin | Lovastatin | 38 | 12 |
| Linzess | Linaclotide | 37 | 12 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 36 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 19 |
| Dexlansoprazole Dr | Dexlansoprazole | 35 | suppressed |
| Famciclovir | Famciclovir | 35 | 27 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 35 | suppressed |
| Aripiprazole | Aripiprazole | 34 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 34 | suppressed |
| Nystatin | Nystatin | 34 | 20 |
| Topiramate | Topiramate | 34 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 33 | suppressed |
| Mirtazapine | Mirtazapine | 33 | suppressed |
| Valsartan | Valsartan | 33 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 32 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 32 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 31 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 31 | suppressed |
| Mupirocin | Mupirocin | 31 | 20 |
| Primidone | Primidone | 31 | suppressed |
| Jardiance | Empagliflozin | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Lansoprazole | Lansoprazole | 29 | suppressed |
| Rybelsus | Semaglutide | 29 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Carisoprodol | Carisoprodol | 28 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 28 | suppressed |
| Carbamazepine | Carbamazepine | 27 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 27 | suppressed |
| Glipizide Er | Glipizide | 26 | suppressed |
| Olanzapine | Olanzapine | 26 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 26 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Naproxen | Naproxen | 25 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 23 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 19 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | 20 |
| Divalproex Sodium | Divalproex Sodium | 23 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 23 | 11 |
| Testosterone Cypionate | Testosterone Cypionate | 23 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 22 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Telmisartan | Telmisartan | 21 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Zaleplon | Zaleplon | 21 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 21 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 17 |
| Rabeprazole Sodium | Rabeprazole Sodium | 20 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 18 | suppressed |
| Risperidone | Risperidone | 18 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 18 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 17 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 13 |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 16 | suppressed |
| Vraylar | Cariprazine Hcl | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 15 | suppressed |
| Diclofenac Sodium-Misoprostol | Diclofenac Sodium/Misoprostol | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Ofloxacin | Ofloxacin | 15 | 13 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 15 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 14 | suppressed |
| Levemir | Insulin Detemir | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Dotti | Estradiol | 13 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 13 | 13 |
| Propafenone Hcl | Propafenone Hcl | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Enulose | Lactulose | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 12 | suppressed |
| Amantadine | Amantadine Hcl | 11 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Niva Thyroid | Thyroid,pork | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $191.00 · 10 records | ABBVIE INC. | MOUNJARO, QULIPTA, TRINTELLIX, The Cologuard Plus Collection Kit, UBRELVY, ZEPBOUND | 7 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error